最近在治疗儿童发作方面的进展
Frank M C Besag1,2,3, Michael J Vasey4, Richard F M Chin5,6
1East London NHS Foundation Trust, Bedford, UK. fbesag@aol.com.
Paediatric drugs
|October 4, 2025
概括
儿童的新疗法正在出现,包括新药,先进的神经刺激和基因疗法. 虽然有希望,但在临床试验中,实现完全的发作自由仍然是这些儿科病的临床试验中的挑战.
科学领域:
- 儿科神经学 儿科神经学
- 发病学 (Epileptology) 是一个专业的学科.
- 翻译医学是一种翻译医学.
背景情况:
- 儿童有多样性,许多病例对标准抗发作药物 (ASM) 具有抗性.
- 像手术这样的现有治疗方法并不总是适合,这凸显了对新型治疗策略的需求.
- 近年来,针对特定综合征的新ASM获得批准,但完全控制发作是罕见的.
研究的目的:
- 审查儿童治疗的最新进展和正在进行的研究.
- 总结新的治疗方法及其对儿科管理的潜在影响.
主要方法:
- 对儿童发作综合征的新抗发作药物 (ASM) 的最新文献的综述.
- 分析不断发展的神经刺激模式,包括响应性和非侵入性系统.
- 探索新兴技术,如聚焦超声波和基因疗法.
主要成果:
- 几种新的ASM (例如,大麻,芬拉胺,Everolimus,Ganaxolone) 已被批准用于特定的综合征,如Lennox-Gastaut综合征和Dravet综合征.
- 神经刺激技术正在向响应性和非侵入性系统发展,在一些研究中显示,与传统方法相比,发作的减少程度相当.
- 基因检测和疗法具有巨大的潜力,通过解决潜在的遗传原因,改变未来的治疗.
结论:
- 尽管取得了进展,但在新ASM的随机对照试验中实现无发作仍然很少.
- 包括先进神经刺激和聚焦超声波在内的创新治疗方法为儿童发作控制提供了新的途径.
- 基因方法代表了个性化和潜在的治疗治疗儿童的有希望的前沿.
相关概念视频
01:24Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
785
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
785
01:08Antiepileptic Drugs: Sodium Channel Blockers
1.5K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.5K
01:13Seizures: Classification
1.3K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.3K
01:14Antiepileptic Drugs: Glutamate Antagonists
851
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
851
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.1K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.1K